Meigen Liu Selected Research

Paresis (Hemiparesis)

1/2021	Effects of hybrid assistive neuromuscular dynamic stimulation therapy for hemiparesis after pediatric stroke: a feasibility trial.
1/2018	Feasibility of task-specific brain-machine interface training for upper-extremity paralysis in patients with chronic hemiparetic stroke.
1/2016	A new therapeutic application of brain-machine interface (BMI) training followed by hybrid assistive neuromuscular dynamic stimulation (HANDS) therapy for patients with severe hemiparetic stroke: A proof of concept study.
4/2015	Brain-computer interface training combined with transcranial direct current stimulation in patients with chronic severe hemiparesis: Proof of concept study.
1/2015	Resting Energy Expenditure in Patients with Stroke during the Subacute Phases - Relationships with Stroke Types, Location, Severity of Paresis, and Activities of Daily Living.
4/2014	Efficacy of brain-computer interface-driven neuromuscular electrical stimulation for chronic paresis after stroke.
9/2012	Modulation of event-related desynchronization during motor imagery with transcranial direct current stimulation (tDCS) in patients with chronic hemiparetic stroke.
1/2012	A pilot study of contralateral homonymous muscle activity simulated electrical stimulation in chronic hemiplegia.
12/2011	Effects of therapeutic gait training using a prosthesis and a treadmill for ambulatory patients with hemiparesis.
6/2004	Physical fitness in persons with hemiparetic stroke: its structure and longitudinal changes during an inpatient rehabilitation programme.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meigen Liu Research Topics

Disease

40	Stroke (Strokes) 06/2022 - 12/2003
11	Paresis (Hemiparesis) 01/2021 - 12/2003
8	Spinal Cord Injuries (Spinal Cord Injury) 12/2019 - 12/2003
5	Paralysis (Palsy) 06/2022 - 10/2011
5	Hemiplegia (Spastic Hemiplegia) 01/2019 - 01/2014
4	Pain (Aches) 11/2018 - 06/2003
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022 - 05/2004
3	Neoplasms (Cancer) 11/2021 - 01/2017
2	Lymphedema (Milroy Disease) 11/2021 - 01/2017
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2021 - 01/2020
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 12/2016
2	Frailty 01/2021 - 12/2016
2	Hyperalgesia 11/2018 - 08/2015
1	Cognitive Dysfunction 01/2021
1	Illusions (Auditory Illusions) 01/2021
1	Heart Failure 01/2021
1	Overactive Urinary Bladder (Overactive Bladder) 01/2020
1	Infections 05/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2019
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2019
1	Coronary Disease (Coronary Heart Disease) 12/2016
1	Cachexia 11/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2016
1	Shoulder Fractures 01/2016
1	Dystonia (Limb Dystonia) 09/2014
1	Muscle Spasticity (Spastic) 09/2014
1	Dystonic Disorders (Writer's Cramp) 09/2014
1	Nervous System Diseases (Neurological Disorders) 04/2014
1	Muscular Dystrophies (Muscular Dystrophy) 09/2010
1	Wounds and Injuries (Trauma) 04/2008
1	Inflammation (Inflammations) 04/2008
1	Atrophy 02/2008
1	Muscular Atrophy (Muscle Atrophy) 02/2008
1	Muscular Diseases (Myopathy) 02/2008
1	Breast Neoplasms (Breast Cancer) 12/2006
1	Congenital Abnormalities (Deformity) 06/2003

Drug/Important Bio-Agent (IBA)

8	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2022 - 09/2010
3	Serum AlbuminIBA 05/2019 - 12/2016
3	PlasticsIBA 01/2019 - 01/2018
2	Therapeutic UsesIBA 11/2021 - 01/2018
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 08/2017
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	DystrophinIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 05/2019
1	C-Reactive ProteinIBA 12/2016
1	Type C PhospholipasesIBA 08/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2015
1	Immunoglobulin G (IgG)IBA 08/2015
1	Botulinum Toxins (Botulinum Toxin)IBA 09/2014
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 08/2010
1	Interleukin-6 (Interleukin 6)IBA 04/2008
1	CytokinesIBA 04/2008
1	Polymethyl Methacrylate (Sol)IBA 02/2008
1	SteroidsIBA 02/2008
1	pyranoprofen (pranoprofen)IBA 12/2006
1	Oxygen (Dioxygen)IBA 06/2004

Therapy/Procedure

17	Brain-Computer Interfaces 06/2022 - 10/2011
16	Therapeutics 06/2022 - 12/2003
11	Activities of Daily Living (ADL) 01/2021 - 06/2003
6	Transcranial Direct Current Stimulation 08/2017 - 01/2011
3	Neurological Rehabilitation 06/2022 - 01/2017
2	Splints (Splint) 01/2021 - 02/2009
2	Neurofeedback 01/2019 - 10/2011
2	Orthotic Devices (Orthosis) 12/2018 - 02/2010
2	Transplantation 11/2018 - 01/2016
1	Mirror Movement Therapy 06/2022
1	Stroke Rehabilitation 01/2022
1	Length of Stay 02/2020
1	Transcatheter Aortic Valve Replacement 01/2020
1	Hysterectomy 01/2020
1	Continuous Positive Airway Pressure 01/2019
1	Occupational Therapy (Therapy, Occupational) 01/2019
1	Enteral Nutrition (Feeding, Tube) 12/2016
1	Drug Therapy (Chemotherapy) 11/2016
1	Exoskeleton Device 01/2016
1	Deep Brain Stimulation 09/2014
1	Injections 09/2014
1	Transcutaneous Electric Nerve Stimulation (TENS) 06/2013
1	Prostheses and Implants (Prosthesis) 12/2011
1	Bathroom Equipment 03/2007
1	Oral Administration 12/2006
1	Surgical Amputation (Amputations) 12/2003